Asia Pacific Drug Delivery Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2025 –2032 |
 Market Size (Base Year) |
USD 32.84 Billion |
 Market Size (Forecast Year) |
USD 58.87 Billion |
 CAGR |
% |
| Major Markets Players |
亚太药物输送市场，按产品（半固体配方、液体配方、固体配方、透皮产品）、给药途径（皮肤给药、眼科给药、直肠给药、阴道给药、鼻腔给药）、最终用途（医院和诊所、烧伤中心、研究机构、家庭护理、其他）– 行业趋势和预测到 2029 年。
亚太药物输送市场分析及规模
创造新的材料或载体系统以有效地输送治疗药物是药物输送领域的一大研究领域。经常使用的药物输送技术包括控制、靶向和稳定药物输送。自从医疗应用系统发展以来，各种药物通过各种常规药物输送剂型被用于治疗各种疾病，例如溶液、洗剂、混合物、乳膏、糊剂、软膏、溶液、粉末、栓剂、注射剂、丸剂、速释胶囊和片剂等。
Data Bridge Market Research 分析，2021 年药物输送市场规模为 26389756 万美元，到 2029 年将飙升至 47311283 万美元，预计在 2022 年至 2029 年的预测期内复合年增长率为 7.57%。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。
亚太药物输送市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020（可定制为 2014 - 2019） |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
产品（半固体制剂、液体制剂、固体制剂、透皮产品）、给药途径（皮肤给药、眼科给药、直肠给药、阴道给药、鼻腔给药）、最终用途（医院和诊所、烧伤中心、研究机构、家庭护理、其他） |
|
覆盖国家 |
亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 其他地区 |
|
涵盖的市场参与者 |
GSK Plc.（英国）、Galderma（瑞士）、Valeant Pharmaceuticals（加拿大）、Hisamitsu Pharmaceuticals Co. Inc.（日本）、Cipla Inc.（印度）、Glenmark（印度）、Johnson & Johnson Private limited（美国）、Novartis AG（德国）、Bayer AG（德国）、Crescita Therapeutics Inc.（加拿大）、Biofarmitalia SRL（意大利）、Pharmatek Laboratories Inc.（美国）、Skin Visible Pharmaceuticals, Inc.（美国）、Mylan NV（美国）、Pocono Coated Products LLC（美国）、SAMYANG HOLDINGS CORPORATION（美国） |
|
Market Opportunities |
|
Market Definition
Tropical drug delivery is the application of medicine to a specific area of the body, typically the skin, mucous membranes, or body surface, to treat illnesses. It is regarded as the best method for treating a localised problem thoroughly. Drugs given through these results penetrate the skin deeply and are more effectively absorbed. These medications are used to treat a variety of ailments, including viral, bacterial, and fungal infections as well as inflammation, warts, and dermatological problems.
Drug Delivery Market Dynamics
Drivers
- Increasing prevalence of skin diseases
The market will be driven by the rising incidence of skin diseases, while the high technological development in the segment of tropical drug delivery, the rising incidence of burn injuries, the rising incidence of diabetic patients, and the rising geriatric population are the factors propelling the market's expansion.
- Rise in the geriatric population
The rising prevalence rates of lifestyle disorders like diabetes and obesity, rising health-care spending, and the fast-growing diagnostic industry are driving the expansion of the drug delivery market. In addition, the growing elderly population, increased demand for laboratory automation, and more awareness of preventative healthcare are all driving the drug delivery market forward.
- Surge in sales of self-injection devices
The surge in sales of self-injection devices is one of the main causes that is predicted to boost the growth and demand of the injectable medication delivery sector. Additionally, the prevalence of chronic diseases like diabetes and cancer is rising, which is contributing to the expansion of the Asia Pacific market.
Opportunities
The market will continue to expand due to the rising need for injectables in the treatment of a wide range of conditions, such as Wilson's disease, autoimmune diseases, haemophilia, hepatitis C, and cystic fibrosis.
Restraints/Challenges
On the other hand, tropical drug limitation in curing area and negative impact of frequent reimbursement will be restraining the market.
This drug delivery market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the drug delivery market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 对药物输送市场的影响
预计药物输送市场将受益于全球免疫接种率的提高。此外，预计第三波 COVID-19 疫情将出现新型病毒株，这将引起人们对治疗研究和药物输送的关注，从而推动市场扩张。
亚太地区药物输送市场范围
药物输送市场根据产品、给药途径和最终用途进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。
产品
- 半固体制剂
- 液体配方
- 固体制剂
- 透皮产品
给药途径
- 皮肤给药
- 眼科药物输送
- 直肠给药
- 阴道给药
- 鼻腔给药
最终用途
- 医院和诊所
- 烧伤中心
- 研究机构
- 家庭护理
- 其他的
药物输送市场区域分析/见解
对药物输送市场进行了分析，并按国家、产品、给药途径和最终用途提供了市场规模见解和趋势，如上所述。
药物输送市场报告涵盖的国家包括亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾和亚太地区 (APAC) 其他地区。
中国由于老年人口的增加以及糖尿病等疾病的流行而占据市场主导地位，从而增加了市场需求。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
竞争格局和药物输送市场份额分析
药物输送市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对药物输送市场的关注有关。
药物输送市场的一些主要参与者包括：
- 葛兰素史克公司（英国）
- 高德美（瑞士）
- Valeant Pharmaceuticals（加拿大）
- 久光制药株式会社 (日本)
- Cipla Inc.（印度）
- 格兰马克（印度）
- 强生私人有限公司（美国）
- 诺华公司（德国）
- 拜耳公司（德国）
- Crescita Therapeutics Inc.（加拿大）
- Biofarmitalia SRL（意大利）
- Pharmatek Laboratories Inc.（美国）
- Skin Visible Pharmaceuticals, Inc.（美国）
- Mylan NV（美国）
- Pocono Coated Products LLC（美国）
- 三养控股株式会社（美国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
